These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 30150398)

  • 1. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Arvanitis CD; Askoxylakis V; Guo Y; Datta M; Kloepper J; Ferraro GB; Bernabeu MO; Fukumura D; McDannold N; Jain RK
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8717-E8726. PubMed ID: 30150398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
    Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
    J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis.
    Lewis Phillips GD; Nishimura MC; Lacap JA; Kharbanda S; Mai E; Tien J; Malesky K; Williams SP; Marik J; Phillips HS
    Breast Cancer Res Treat; 2017 Aug; 164(3):581-591. PubMed ID: 28493046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.
    Martin M; Fumoleau P; Dewar JA; Albanell J; Limentani SA; Campone M; Chang JC; Patre M; Strasak A; de Haas SL; Xu J; Garcia-Saenz JA
    Ann Oncol; 2016 Jul; 27(7):1249-56. PubMed ID: 27052654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
    Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
    Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.
    Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N
    J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.
    Wu SK; Chiang CF; Hsu YH; Lin TH; Liou HC; Fu WM; Lin WL
    Int J Nanomedicine; 2014; 9():4485-94. PubMed ID: 25278753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
    Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
    Jung B; Huh H; Lee EH; Han M; Park J
    J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
    Wyatt EA; Davis ME
    Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
    Lin YL; Wu MT; Yang FY
    J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.
    Kim C; Guo Y; Velalopoulou A; Leisen J; Motamarry A; Ramajayam K; Aryal M; Haemmerich D; Arvanitis CD
    Theranostics; 2021; 11(15):7276-7293. PubMed ID: 34158850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment.
    Baker JHE; Kyle AH; Reinsberg SA; Moosvi F; Patrick HM; Cran J; Saatchi K; Häfeli U; Minchinton AI
    Clin Exp Metastasis; 2018 Oct; 35(7):691-705. PubMed ID: 30196384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
    Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
    J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.